Insulin pump-maker Insulet has scored FDA 510(k) clearance for its Omnipod 5 Automated Insulin Delivery System for people ages 6 and up with Type 1 diabetes. The pump integrates with the Dexcom G6 continuous glucose monitor to automatically adjust insulin levels depending on blood glucose. It can be worn for up to 72 hours.
Users can control their pump and share data from an app if they have a...
Insulin pump maker Insulin announced partnerships yesterday with two of the leading continuous glucose monitor companies, Abbott and Dexcom. Both involve the Insulet’s Omnipod Horizon Automated Insulin Delivery System which uses a tubeless, wearable “Pod” to deliver insulin for 72 hours at a time.
Abbott and Insulet have partnered to offer a new integrated digital health platform that will...
Editor's note: The headline and body of this article has been edited to clarify that Samsung's integration with the Omnipod Dash have not yet been implemented.
Samsung Galaxy smartphones will be serving as the controlling device for Billerica, Massachusetts-based Insulet Corporation’s tubeless insulin pump devices, the two companies announced today.
Insulet’s recently FDA-cleared Omnipod Dash...
Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash Insulin Management System.
“Omnipod Dash was inspired by Podders and embodies what users on multiple daily injections have been asking for in a diabetes management system,” Patrick Sullivan, chairman and...
Insulet, maker of the OmniPod insulin pump, has launched a new tablet app aimed at children. The app, called Toby's T1D Tale, is essentially a virtual story book intended for teaching young children with Type 1 diabetes about diabetes and how to manage it.
“We’ve worked closely with several providers, including a pediatric psychologist, caregivers and our clinical team to deliver a credible...
The Dexcom Follow Android App
Diabetes management software company Glooko will add its first two continuous glucose monitor and pump integrations into its offering: Dexcom's G4 CGM and Insulet's OmniPod Insulin Management System.
The company announced in March that it would begin to incorporate pumps and CGMs into its system, including those from Medtronic, an investor in Glooko's latest $16.5...
